HCV Guidance Panel

Current Chairs

Andrew I. Aronsohn, MD

University of Chicago Medical Center

Debika Bhattacharya, MD

University of California Los Angeles

Vincent Lo Re, MD, MSCE

University of Pennsylvania School of Medicine

Jennifer C. Price, MD, PhD

University of California

Current Panel Members

Matthew J Akiyama, MD, MSc

Albert Einstein College of Medicine

Jordan J. Feld, MD, MPH

Toronto Western Hospital Liver Center

Theo Heller, MD

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

H. Nina Kim, MD MSc

University of Washington

Tatyana Kushner, MD, MSCE

Icahn School of Medicine at Mount Sinai

Joseph K. Lim, M.D.

Yale University School of Medicine

Benjamin P. Linas, MD, MPH

Boston University School of Medicine

Michelle T. Martin, PharmD, FCCP, BCPS, BCACP

College of Pharmacy

Natasha Martin, DPhil

University of California San Diego

Ponni Perumalswami, MD

University of Michigan

Gloria Searson, ACSW

Coalition on Positive Health Empowerment

Norah A. Terrault, MD

Keck Medicine at University of Southern California

Jessie Torgersen, MD

University of Pennsylvania

Elizabeth C. Verna, MD, MS

Columbia University Medical Center

Carolyn Wester, MD

CDC, National Center for HIV, Viral Hepatitis, STD, and TB Prevention

Ann E. Woolley, MD, MPH

Brigham and Women’s Hospital

Harvard Medical School

Kim Workowski, MD

Emory University School of Medicine

Past Chairs

Raymond T. Chung, MD

Massachusetts General Hospital

Co-Chair: 2015-2017

Panel Member: 2013-2014

Gary L. Davis, MD

Baylor University Medical Center (retired)

2013-2015

Marc G. Ghany, MD, MHSc* **

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Co-Chair: 2018-2020

Panel Member: 2016-2017

Donald M. Jensen, MD

University of Chicago Medical Center (retired)

2013-2014

Arthur Y. Kim, MD

Harvard Medical School

Co-Chair: 2015-2018

Panel Member: 2013-2015

Kristen M. Marks, MD

Weill Cornell Medical College

Co-Chair: 2018-2020

Panel Member: 2013-2017

Henry Masur, MD* **

National Institutes of Health

2013-2015

Timothy R. Morgan, MD

Veterans Affairs Long Beach Healthcare System

Co-chair: 2019-2022

Panel member: 2013-2018

Susanna Naggie, MD

Duke University School of Medicine

Durham VA Medical Center

Co-Chair: 2015-2017

Panel Member: 2013-2014

Michael S. Saag, MD

The University of Alabama at Birmingham

2013-2015

David L. Thomas, MD, MPH

The Johns Hopkins University School of Medicine

2013-2015

Hugo E. Vargas, MD

College of Medicine, Mayo Clinic

Co-Chair: 2015-2018

Panel Member: 2013-2015

David L. Wyles, MD

Denver Health

Co-chair: 2018-2022

Panel member: 2013-2016

Past Panel Members

Tina Broder, MSW, MPH

Building Equity and Alignment for Impact

2016-2020

Michael R. Charlton, MD

Intermountain Medical Center

2013-2016

Oluwaseun O. Falade-Nwulia, MBBS, MPH

Johns Hopkins University School of Medicine

10/2015-11/2019

Robert J. Fontana, MD

University of Michigan Medical School

2013-2017

Eliot W. Godofsky, MD, FACP

Bach and Godofsky, Infectious Diseases

2013-2016

Stuart C. Gordon, MD

Henry Ford Health System/Division of Hepatology

2016-2022

Camilla S. Graham, MD, MPH

TREK Therapeutics, PBC

2014-2015

Scott D. Holmberg, MD** +

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

2015-2018

Ravi Jhaveri MD, FIDSA, FPIDS, FAAP

Ann & Robert H. Lurie Children's Hospital of Chicago

Professor of Pediatrics, Feinberg Northwestern School of Medicine

Maureen M. Jonas, MD

Harvard Medical School

Boston Children’s Hospital

2016-2022

Jennifer J. Kiser, PharmD, PhD

University of Colorado

Skaggs School of Pharmacy and Pharmaceutical Sciences

Shyam Kottilil, MD, PhD

Division of Infectious Diseases

Institute of Human Virology/University of Maryland

2013-2016

Paul Martin, MD

University of Miami School of Medicine

2013-2016

Kiren Mitruka, MD, MPH** +

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

2013-2015

Ronald G. Nahass, MD, MHCM, FACP, FIDSA

ID Care

2015-2018

Marion G. Peters, MD

University of California San Francisco

10/2015-11/2019

Daniel Raymond

Harm Reduction Coalition

2013-2017

Nancy S. Reau, MD

Rush University Medical Center

2013-2016

K. Rajender Reddy, MD

Hospital of the University of Pennsylvania

2015-2022

Andrew Reynolds

San Francisco AIDS Foundation

Robert T. Schooley, MD

University of California San Diego

2013-2015

John D. Scott, MD, MSc, FIDSA

Hepatitis and Liver Clinic

University of Washington

2015-2022

Kenneth E. Sherman

University of Cincinnati College of Medicine

2013-2015

Philip Spradling, MD **+

Centers for Disease Control and Prevention

Mark S. Sulkowski, MD

The Johns Hopkins University School of Medicine

2013-2015

Tracy Swan

Treatment Action Group

2015-2018

Stacey B. Trooskin, MD, PhD

Jonathan Lax Treatment Center

Philadelphia FIGHT

John W. Ward, MD** +

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

2013-2015

John B. Wong, MD

Tufts University School of Medicine

Contributors

Saleem Kamili, PhD**

Division of Viral Hepatitis

Centers for Disease Control and Prevention

Mona R. Prasad, DO, MPH

Division of Maternal Fetal Medicine, The Ohio State University

Laura E. Riley, MD

Division of Maternal Fetal Medicine, Massachusetts General Hospital

Tina M. St. John, MD

St. John Health Communications & Consulting

Judith Welsh, BS, MLS* **

NIH Library

National Institutes of Health

Rachel J. Wilson**

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

Acknowledgement

The International Antiviral Society–USA (IAS–USA) served as the collaborating partner for the HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C from the project’s inception in mid- 2013 through 2015. IAS-USA was responsible for managing the writing panel and the guidance development process. A representative from IAS–USA also served as a co-chair of the HCV Guidance Panel. Due to priorities related to their core mission, IAS-USA elected to end their relationship as collaborating partner on December 31. AASLD and IDSA recognize IAS-USA’s tremendous contribution to the HCV Guidance and the creation and maintenance of www.hcvguidelines.org. Special appreciation is extended to the following individuals for their outstanding service:

Michael Saag, MD
Donna Jacobsen
Cindy Downing
Michelle Valderama
Jennezel Peneda
Rachel Lastra